Coya Therapeutics, Inc. (COYA) SEC Filings — 2024
20 SEC filings for Coya Therapeutics, Inc. (COYA) in 2024.
Filings
- Coya Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Coya Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 6, 2024
- Coya Therapeutics Appoints New Director, Discloses Officer Compensation — 8-K · Nov 5, 2024
- Coya Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Coya Therapeutics Appoints New Director — 8-K · Oct 31, 2024
- Coya Therapeutics Files 8-K — 8-K · Oct 29, 2024
- Coya Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Oct 22, 2024
- Coya Therapeutics Relocates Principal Executive Offices — 8-K · Aug 19, 2024
- Coya Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- Coya Therapeutics Appoints New CEO — 8-K · Jul 15, 2024
- Coya Therapeutics Enters Material Definitive Agreement — 8-K · Jun 5, 2024
- Coya Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · May 20, 2024
- Coya Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Coya Therapeutics Files 8-K: Director, Officer, and Compensation Updates — 8-K · May 8, 2024
- Coya Therapeutics Files Proxy Materials — DEFA14A · Mar 29, 2024
- Coya Therapeutics, Inc. Announces Annual Meeting of Stockholders on May 8, 2024 — DEF 14A · Mar 28, 2024
- Coya Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 19, 2024
- Coya Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- AIGH Capital Management Discloses 7.2% Stake in Coya Therapeutics — SC 13G/A · Feb 7, 2024
- Coya Therapeutics Updates Business Address in Houston — 8-K · Jan 19, 2024